Rablax Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.60 M
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Rablax Pharma
Rablax Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 August 2022 (Two years and six months 2 days old ). Its registered office is in Bardhaman, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Bikram Hazra, Sudhir Barnwal, and Sourin Mondal serve as directors at the Company.
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB2022PTC256595
- Company No.
256595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Rablax Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bikram Hazra  | Director | 24-Aug-2022 | Current |
| Sudhir Barnwal | Director | 24-Aug-2022 | Current |
| Sourin Mondal | Director | 24-Aug-2022 | Current |
Financial Performance of Rablax Pharma.
Enhance accessibility to Rablax Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rablax Pharma?
Unlock access to Rablax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Satyavache Development LlpBikram Hazra is a mutual person
- Saptaprodip Infracon Private Limited
Bikram Hazra and Sudhir Barnwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rablax Pharma?
Rablax Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rablax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rablax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.